Last reviewed · How we verify
Caphosol® Versus State-of-the-art Mouthcare in Patients With Allogeneic Stem Cell Transplantation: a Randomized Controlled Study About the Efficacy of the Mouth Rinse Caphosol®
Randomized controlled study about the efficacy of the mouth rinse Caphosol in patients with allogeneic stem cell transplantation. 85% of the patients receive a severe oral mucositis due to their treatment. 70 patients will be randomized in the intervention (Caphosol) or in the standard (state-of-the-art) group. Primary endpoint is the duration of the mucositis, secondary endpoints are the occurence of oral mucositis measured with the WHO-scale and the occurence of pain measured with the NRS-scale (Numeric Rating Scale). * Trial with medical device
Details
| Lead sponsor | University of Zurich |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 72 |
| Start date | 2013-01 |
| Completion | 2014-08 |
Conditions
- Allogeneic Stem Cell Transplantation
Interventions
- Caphosol
Primary outcomes
- Duration of oral mucositis — 20-30 days
Countries
Switzerland